stock
KMTS · KESTRA MEDICAL TECHNOLOGIES, LTD.
What KESTRA MEDICAL TECHNOLOGIES, LTD. reports to the SEC, read from its filings.
Open in the appPrice
The live KMTS price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on KMTS.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 59,561,795 as of 2026-09-11 (XBRL frame CY2026Q3I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- 53.9%
- Operating
- -134.5%
- Net
- -140.4%
Returns
- ROE
- -67.4%
- ROA
- -43.1%
Health
- Current ratio
- 4.7x
- Debt/equity
- 0.3x
Deep value
- NCAV
- $101.28M
- NCAV per share
- $1.70
- Price/NCAV
- Locked
- NNWC
- -$56.44M
- NNWC per share
- -$0.95
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-07-31; balance sheet at 2026-07-31.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-07-31 | $30.97M | $17.50M | -$37.66M | -$44.09M | 10-Q filed 2026-09-14 |
| 2026-04-30 | $28.64M | $15.68M | -$39.34M | -$38.84M | 10-K filed 2026-07-14 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2026-01-31 | $24.55M | $12.91M | -$34.77M | -$34.17M | 10-Q filed 2026-03-17 |
| 2025-10-31 | $22.57M | $11.42M | -$31.75M | -$32.78M | 10-Q filed 2025-12-11 |
| 2025-07-31 | $19.37M | $8.85M | -$28.88M | -$25.83M | 10-Q filed 2026-09-14 |
| 2025-04-30 | $17.23M | $7.63M | -$48.21M | -$52.05M | 10-K filed 2026-07-14 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. |
| 2025-01-31 | $15.09M | $6.55M | -$20.60M | -$21.51M | 10-Q filed 2026-03-17 |
| 2024-10-31 | $14.71M | $5.83M | -$19.13M | -$20.37M | 10-Q filed 2025-12-11 |
- Assets
- $347.36M
- Equity
- $222.36M
Balance as of 2026-07-31.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2026-04-30 | $95.13M | -$134.74M | -$131.61M | -$116.59M |
| 2025-04-30 | $59.81M | -$106.38M | -$113.81M | -$100.54M |
| 2024-04-30 | $27.81M | -$85.06M | -$94.12M | -$84.46M |
Company filings
since Wed Apr 1 · 1 offering filing in 12 months
events
5% owners ()
T. Rowe Price Associates, Inc.
Stake update
T. Rowe Price Associates, Inc.
Stake update
Bain Charger Holdings, L.P.
Stake update
Endeavour Medtech Growth II LP
Stake update
T. Rowe Price Associates, Inc.
Passive stake
Insiders, politicians and funds
Insider trades, last 90 days
COHEN RAYMOND W
Director
Sale$97,504Oct 1, 6:00 PM ET
Kwo Elizabeth
Director
Sale$97,268Sep 23, 6:04 PM ET
Schwartz Jeffrey Lawrence
Director, 10% owner
Sale$97,942Sep 10, 8:43 PM ET
Hanley Conor
Director
Sale$143,779Sep 10, 8:28 PM ET
Reilly Kevin C
Director
Sale$73,677Sep 10, 8:26 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
News
Stories that named KMTS, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about KMTS.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on KMTS come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the KMTS board